NF-κB-Mediated Regulation of Osteoclastogenesis

Osteoclasts are multinucleated cells formed mainly on bone surfaces in response to cytokines by fusion of bone marrow-derived myeloid lineage precursors that circulate in the blood. Major advances in understanding of the molecular mechanisms regulating osteoclast formation and functions have been ma...

Full description

Bibliographic Details
Main Authors: Brendan F. Boyce, Yan Xiu, Jinbo Li, Lianping Xing, Zhenqiang Yao
Format: Article
Language:English
Published: Korean Endocrine Society 2015-03-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-30-35.pdf
_version_ 1818357839114010624
author Brendan F. Boyce
Yan Xiu
Jinbo Li
Lianping Xing
Zhenqiang Yao
author_facet Brendan F. Boyce
Yan Xiu
Jinbo Li
Lianping Xing
Zhenqiang Yao
author_sort Brendan F. Boyce
collection DOAJ
description Osteoclasts are multinucleated cells formed mainly on bone surfaces in response to cytokines by fusion of bone marrow-derived myeloid lineage precursors that circulate in the blood. Major advances in understanding of the molecular mechanisms regulating osteoclast formation and functions have been made in the past 20 years since the discovery that their formation requires nuclear factor-kappa B (NF-κB) signaling and that this is activated in response to the essential osteoclastogenic cytokine, receptor activator of NF-κB ligand (RANKL), which also controls osteoclast activation to resorb (degrade) bone. These studies have revealed that RANKL and some pro-inflammatory cytokines, including tumor necrosis factor, activate NF-κB and downstream signaling, including c-Fos and nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), and inhibition of repressors of NFATc1 signaling, to positively regulate osteoclast formation and functions. However, these cytokines also activate NF-κB signaling that can limit osteoclast formation through the NF-κB signaling proteins, TRAF3 and p100, and the suppressors of c-Fos/NFATc1 signaling, IRF8, and RBP-J. This paper reviews current understanding of how NF-κB signaling is involved in the positive and negative regulation of cytokine-mediated osteoclast formation and activation.
first_indexed 2024-12-13T20:19:29Z
format Article
id doaj.art-cd85988a34694c718ef4d47927f0db3a
institution Directory Open Access Journal
issn 2093-596X
2093-5978
language English
last_indexed 2024-12-13T20:19:29Z
publishDate 2015-03-01
publisher Korean Endocrine Society
record_format Article
series Endocrinology and Metabolism
spelling doaj.art-cd85988a34694c718ef4d47927f0db3a2022-12-21T23:32:44ZengKorean Endocrine SocietyEndocrinology and Metabolism2093-596X2093-59782015-03-01301354410.3803/EnM.2015.30.1.3520829NF-κB-Mediated Regulation of OsteoclastogenesisBrendan F. BoyceYan XiuJinbo LiLianping XingZhenqiang YaoOsteoclasts are multinucleated cells formed mainly on bone surfaces in response to cytokines by fusion of bone marrow-derived myeloid lineage precursors that circulate in the blood. Major advances in understanding of the molecular mechanisms regulating osteoclast formation and functions have been made in the past 20 years since the discovery that their formation requires nuclear factor-kappa B (NF-κB) signaling and that this is activated in response to the essential osteoclastogenic cytokine, receptor activator of NF-κB ligand (RANKL), which also controls osteoclast activation to resorb (degrade) bone. These studies have revealed that RANKL and some pro-inflammatory cytokines, including tumor necrosis factor, activate NF-κB and downstream signaling, including c-Fos and nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), and inhibition of repressors of NFATc1 signaling, to positively regulate osteoclast formation and functions. However, these cytokines also activate NF-κB signaling that can limit osteoclast formation through the NF-κB signaling proteins, TRAF3 and p100, and the suppressors of c-Fos/NFATc1 signaling, IRF8, and RBP-J. This paper reviews current understanding of how NF-κB signaling is involved in the positive and negative regulation of cytokine-mediated osteoclast formation and activation.http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-30-35.pdfNF-kappa BOsteoclastsRANK ligandTumor necrosis factorTNF receptor-associated factor 3NF-kappa B kinase
spellingShingle Brendan F. Boyce
Yan Xiu
Jinbo Li
Lianping Xing
Zhenqiang Yao
NF-κB-Mediated Regulation of Osteoclastogenesis
Endocrinology and Metabolism
NF-kappa B
Osteoclasts
RANK ligand
Tumor necrosis factor
TNF receptor-associated factor 3
NF-kappa B kinase
title NF-κB-Mediated Regulation of Osteoclastogenesis
title_full NF-κB-Mediated Regulation of Osteoclastogenesis
title_fullStr NF-κB-Mediated Regulation of Osteoclastogenesis
title_full_unstemmed NF-κB-Mediated Regulation of Osteoclastogenesis
title_short NF-κB-Mediated Regulation of Osteoclastogenesis
title_sort nf κb mediated regulation of osteoclastogenesis
topic NF-kappa B
Osteoclasts
RANK ligand
Tumor necrosis factor
TNF receptor-associated factor 3
NF-kappa B kinase
url http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-30-35.pdf
work_keys_str_mv AT brendanfboyce nfkbmediatedregulationofosteoclastogenesis
AT yanxiu nfkbmediatedregulationofosteoclastogenesis
AT jinboli nfkbmediatedregulationofosteoclastogenesis
AT lianpingxing nfkbmediatedregulationofosteoclastogenesis
AT zhenqiangyao nfkbmediatedregulationofosteoclastogenesis